Compare Novartis AG (NVS) vs VanEck Rare Earth/Strategic Metals (REMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs VanEck Rare Earth/Strategic Metals — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while VanEck Rare Earth/Strategic Metals trades at $72.06. The key difference: Novartis AG pays a 3.17% dividend while VanEck Rare Earth/Strategic Metals pays none, and Novartis AG is trading nearer its 52-week high, VanEck Rare Earth/Strategic Metals nearer its low. Which is the better fit depends on your goals.
| NVS | REMX | |
|---|---|---|
Market Cap | $290.25B | — |
Sector | Health | Sector/Thematic |
52-Week High | $168.62 | $109.53 |
52-Week Low | $113.50 | $49.22 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About VanEck Rare Earth/Strategic Metals
REMX invests in global companies involved in producing, refining, and recycling rare earth and strategic metals. It provides targeted exposure to critical minerals used in high-tech and green energy, with top holdings like Albemarle and Pilbara Minerals.
Read more on REMX →
